ClinicalTrials.gov
public full text
Public Domain
Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy
Observational long-term follow-up study of patients who have been exposed to a gene-modified cell therapy produced by ex vivo transduction of immune cells expressing viral or non-viral vectors in studies sponsored by Sorrento Therapeutics, Inc.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells#841050
- Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors#904256
- Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia#1124809
- Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A#905854
- Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications#1175095
Record · ID 1086828
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive